Found: 18
Select item for more details and to access through your institution.
Erythrocytosis, thrombocytosis, and rate of recurrent thromboembolic event—A population based cohort study.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 6, p. 608, doi. 10.1111/ejh.13938
- By:
- Publication type:
- Article
Survival and risk of vascular complications in myelofibrosis—A population‐based study from the Swedish MPN group.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 4, p. 336, doi. 10.1111/ejh.13813
- By:
- Publication type:
- Article
Highly reduced survival in essential thrombocythemia and polycythemia vera patients with vascular complications during follow‐up.
- Published in:
- European Journal of Haematology, 2020, v. 104, n. 3, p. 271, doi. 10.1111/ejh.13373
- By:
- Publication type:
- Article
Genetic variation in <italic>IL28B</italic> (<italic>IFNL3</italic>) and response to interferon‐alpha treatment in myeloproliferative neoplasms.
- Published in:
- European Journal of Haematology, 2018, v. 100, n. 5, p. 419, doi. 10.1111/ejh.13034
- By:
- Publication type:
- Article
Risk factors for vascular complications and treatment patterns at diagnosis of 2389 PV and ET patients: Real-world data from the Swedish MPN Registry.
- Published in:
- European Journal of Haematology, 2017, v. 98, n. 6, p. 577, doi. 10.1111/ejh.12873
- By:
- Publication type:
- Article
Increased risk for vascular complications in PRV-1 positive patients with essential thrombocythaemia.
- Published in:
- British Journal of Haematology, 2003, v. 123, n. 3, p. 513, doi. 10.1046/j.1365-2141.2003.04634.x
- By:
- Publication type:
- Article
The clinical relevance of broad mutational screening of myeloproliferative neoplasms at diagnosis.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1190305
- By:
- Publication type:
- Article
Increased incidence of another cancer in myeloproliferative neoplasms patients at the time of diagnosis.
- Published in:
- European Journal of Haematology, 2015, v. 94, n. 2, p. 152, doi. 10.1111/ejh.12410
- By:
- Publication type:
- Article
Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study.
- Published in:
- European Journal of Haematology, 2012, v. 88, n. 6, p. 485, doi. 10.1111/j.1600-0609.2012.01775.x
- By:
- Publication type:
- Article
The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera.
- Published in:
- European Journal of Haematology, 2011, v. 86, n. 2, p. 148, doi. 10.1111/j.1600-0609.2010.01548.x
- By:
- Publication type:
- Article
AML transformation in 56 patients with Ph− MPD in two well defined populations.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 2, p. 106, doi. 10.1111/j.1600-0609.2008.01163.x
- By:
- Publication type:
- Article
The presence of a significant association between elevated PRV-1 mRNA expression and low plasma erythropoietin concentration in essential thrombocythaemia.
- Published in:
- European Journal of Haematology, 2003, v. 70, n. 6, p. 358, doi. 10.1034/j.1600-0609.2003.00079.x
- By:
- Publication type:
- Article
Patients with idiopathic myelofibrosis show increased CD34<sup>+</sup> cell concentrations in peripheral blood compared to patients with polycythaemia vera and essential thrombocythaemia.
- Published in:
- European Journal of Haematology, 2002, v. 68, n. 4, p. 189, doi. 10.1034/j.1600-0609.2002.01610.x
- By:
- Publication type:
- Article
Hydroxyurea treatment reduces haematopoietic progenitor growth and CD34 positive cells in polycythaemia vera and essential thrombocythaemia.
- Published in:
- European Journal of Haematology, 2000, v. 64, n. 3, p. 188, doi. 10.1034/j.1600-0609.2000.90052.x
- By:
- Publication type:
- Article
Increase of CD34 positive cells in polycythaemia vera.
- Published in:
- European Journal of Haematology, 1997, v. 59, n. 3, p. 171, doi. 10.1111/j.1600-0609.1997.tb00971.x
- By:
- Publication type:
- Article
Thromboembolic events, major bleeding and mortality in essential thrombocythaemia and polycythaemia vera—A matched nationwide population‐based study.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 5, p. 1740, doi. 10.1111/bjh.19337
- By:
- Publication type:
- Article
ASXL1 mutations, previous vascular complications and age at diagnosis predict survival in 85 WHO‐defined polycythaemia vera patients.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 5, p. 913, doi. 10.1111/bjh.16450
- By:
- Publication type:
- Article
Improved MPL mutation screening with multiplex PCR and capillary electrophoresis.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 5, p. 838, doi. 10.1111/bjh.14253
- By:
- Publication type:
- Article